Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for CorMedix (CRMD) over the last 13 years, with Q3 2025 value amounting to $16.3 million.

  • CorMedix's Prepaid Assets rose 45976.52% to $16.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.3 million, marking a year-over-year increase of 45976.52%. This contributed to the annual value of $3.6 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that CorMedix reported Prepaid Assets of $16.3 million as of Q3 2025, which was up 45976.52% from $4.7 million recorded in Q2 2025.
  • In the past 5 years, CorMedix's Prepaid Assets ranged from a high of $16.3 million in Q3 2025 and a low of $530852.0 during Q3 2022
  • Moreover, its 5-year median value for Prepaid Assets was $1.3 million (2023), whereas its average is $2.7 million.
  • Its Prepaid Assets has fluctuated over the past 5 years, first plummeted by 5866.35% in 2022, then soared by 45976.52% in 2025.
  • CorMedix's Prepaid Assets (Quarter) stood at $770485.0 in 2021, then fell by 19.05% to $623672.0 in 2022, then soared by 101.24% to $1.3 million in 2023, then soared by 189.59% to $3.6 million in 2024, then surged by 349.22% to $16.3 million in 2025.
  • Its Prepaid Assets stands at $16.3 million for Q3 2025, versus $4.7 million for Q2 2025 and $5.1 million for Q1 2025.